5
Total investments
1
Early stage
1
Mid stage
3
Late stage
8y
Years active
Portfolio
5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Sep 2021
Sana is a digital health company driven by 25 years of research. The innovative audiovisual technology allows you to accelerate your physical recovery and improve your mental well-being, offering a more restful state of mind. The Sana device is not currently approved by the FDA for any medical condition and should be used for the purposes of rest and recovery only, until such time as appropriate clinical evidence is approved through FDA processes.
Board Observer
Sep 2020
Orbita’s award-winning, HIPAA-compliant conversational AI platform powers voice and chat solutions for healthcare and life sciences organizations that improve patient engagement, increase clinical efficiency, and improve outcomes. Customers include innovative organizations like Mass General Brigham, Mayo Clinic, Amwell, Yale New Haven Hospital, Cancer Treatment Centers of America, University of Chicago Medicine, and others. Partners included Cognizant, Deloitte, Pariveda, and ServiceNow.
Board Observer
May 2019
Living with a serious illness can be difficult for patients and their families. VyncaCare is committed to empowering individuals, their loved ones, and their care teams with serious illness solutions that deliver care in their homes. By providing interdisciplinary care teams and advance care planning, we ensure that the uncertainty surrounding serious illness and complex health conditions are met in a compassionate way.
Board Observer
Mar 2019
We’re moving! Stay connected with the Invitae Ciitizen community by following us on Linked, @Invitae
Board Observer
May 2018
Gauss is the leader in computer vision in healthcare. Founded in 2011, Gauss’s mission is to digitally augment clinicians with software that radically improves diagnostic accuracy and leads to improved patient safety and clinical outcomes. Gauss’s flagship product, Triton, leverages computer vision to detect surgical and obstetric hemorrhage in real time and notifies clinicians who can enact timely intervention and treatment. Triton was granted De Novo clearance from the U.S. Food and Drug Administration (FDA) in 2014, as the first-ever computer vision software for surgical use, and several follow-on 510(k) clearances. Available on the iPhone, Triton has been widely adopted by health systems in the United States and is a recipient of the Apple Design Award, which recognizes the best in design, innovation and technology on Apple platforms. Gauss was acquired by Stryker (NYSE: SYK) in 2021. For more information, visit http://www.gauss.com.
Experience · 7 entries
All (7)
Investments (5)
Board (5)
2026
2021
Board Observer
Sep 2021
Sana is a digital health company driven by 25 years of research. The innovative audiovisual technology allows you to accelerate your physical recovery and improve your mental well-being, offering a more restful state of mind. The Sana device is not currently approved by the FDA for any medical condition and should be used for the purposes of rest and recovery only, until such time as appropriate clinical evidence is approved through FDA processes.
2020
Board Observer
Sep 2020
Orbita’s award-winning, HIPAA-compliant conversational AI platform powers voice and chat solutions for healthcare and life sciences organizations that improve patient engagement, increase clinical efficiency, and improve outcomes. Customers include innovative organizations like Mass General Brigham, Mayo Clinic, Amwell, Yale New Haven Hospital, Cancer Treatment Centers of America, University of Chicago Medicine, and others. Partners included Cognizant, Deloitte, Pariveda, and ServiceNow.
T
The 4100 Group, Inc.
Managing Director, VC/PE Private Market Investments
Jun 2020
2019
Board Observer
May 2019
Living with a serious illness can be difficult for patients and their families. VyncaCare is committed to empowering individuals, their loved ones, and their care teams with serious illness solutions that deliver care in their homes. By providing interdisciplinary care teams and advance care planning, we ensure that the uncertainty surrounding serious illness and complex health conditions are met in a compassionate way.
Show all 7 entries ↓
Investment activity
2018–2021 · 5 investments
Recent (last 2 years)Earlier